Nov. 18, 2017:

The only thing as exciting as the teams competing on the field is the team fighting cancer – the Big Ten Cancer Research Consortium. The member institutions are driving science rapidly from new ideas to new treatments, and they do not wait for anyone to catch up.  So keep up, with this month’s Across the Consortium!

Read More

Nov. 2, 2017:

The Big Ten Cancer Research Consortium recently welcomed as a member of its steering committee Anne Schott, MD, clinical professor of medicine and associate director of clinical research at the University of Michigan Comprehensive Cancer Center. The committee consists of one representative from each member institution and is responsible to decide matters of policy for the consortium.

A Gulf Coast native, Schott attended medical school at the University of South Alabama. She completed a medical internship and residency at University of Virginia and then a fellowship in hematology-oncology at the University of Michigan. Read More

Nov. 1, 2017:

Investigator Spotlight

Dr. Zachary Morris is an Assistant Professor in the Department of Human Oncology at the University of Wisconsin School of Medicine and Public Health and is a member of the UW Carbone Cancer Center.

This story is adapted from an earlier version, originally published by UW Health

Teaching the Immune System to Fight Cancer

Vaccines against an infection work by training the immune system at the site of injection and then spreading those educated immune cells throughout the body.

UW Carbone Cancer Center researcher and Big Ten Cancer Research Consortium (Big Ten CRC) Head and Neck Clinical Trial Working Group member Zachary Morris, MD, PhD, thinks that same immunotherapy concept can be applied to fighting cancer, especially metastatic cancers where cells from the initial tumor have spread to other parts of the body. Morris is also working with Big Ten CRC to launch a Sarcoma Clinical Trial Working Group.

Read More